To know whether blocking the function of corticosteroids locally in bilateral DGs can affect the effect of stress on anxiety behavior, we infused the glucocorticoids receptor antagonist, spironolactone (50 μM, 0.25 μL/h), into the DGs using osmotic minipumps during CUMS. The gene discussed is NR3C1; the disease is Anxiety.